Easom Eric

CIK 00019145031 companyMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001914503

Recent Transactions

35 trades

Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-06-02$1.07/sh+10,000→ 256,380 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2025-02-26+290,500→ 290,500 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-02-26+145,250→ 246,380 total
Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-11-18$1.00/sh+50,000→ 1,065,766 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+99,000→ 101,130 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+99,000→ 101,130 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-03-15+198,000→ 198,000 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-01-02$20.09/sh−2,777→ 2,130 total
Purchase
AN2 Therapeutics, Inc.$ANTX
Common Stock
2023-05-15$5.38/sh+10,000→ 1,015,766 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-02-23+267,650→ 267,650 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-14$15.04/sh−23→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-10$15.32/sh−4,413→ 4,930 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-09$15.61/sh−10,111→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-08$15.41/sh−5,800→ 16,273 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-08$16.38/sh−1,255→ 15,018 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-07$16.72/sh−2,036→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-07$15.90/sh−10,167→ 6,943 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-04$15.80/sh−8,828→ 17,110 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-03$15.67/sh−11,082→ 29,021 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-03$16.02/sh−3,083→ 25,938 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-11-02$15.07/sh−1,544→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-31$15.39/sh−2,688→ 6,451 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-28$15.09/sh−1,683→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-27$15.36/sh−924→ 6,590 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-26$15.10/sh−1,678→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-25$16.20/sh−534→ 6,585 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-25$15.69/sh−4,272→ 7,119 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-24$16.17/sh−2,866→ 11,391 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-21$16.69/sh−2,350→ 4,907 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-21$16.29/sh−11,601→ 7,257 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-20$17.15/sh−31→ 18,858 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-10-20$16.68/sh−7,262→ 18,889 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+225,000→ 225,000 total
Conversion
AN2 Therapeutics, Inc.$ANTX
Common Stock
2022-03-29+4,907→ 4,907 total
Conversion
AN2 Therapeutics, Inc.$ANTX
Series A Convertible Preferred Stock
2022-03-29−4,907→ 0 total

Companies

AN2 Therapeutics, Inc.
Director, Chief Executive Officer
$ANTX

Recent Filings

Address

C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D

MENLO PARK, CA, 94027

View on SEC.gov